Tag:

nanoparticles

Latest Headlines

Latest Headlines

Synthetic protein tricks immune system for drug delivery, device safety

Researchers at the University of Pennsylvania have found a way to coat small drug-delivery vehicles and other foreign objects with a synthetic "passport" peptide that fools the immune system into allowing the objects to survive longer in the human body.

BIND Biosciences strives for 'revolutionary' nanomedicine

When it comes to drug delivery, it's hard these days to overlook the buzzing field of nanoengineering. Highly targeted nanoparticles are on the cutting edge of the growing field, and according to BIND Biosciences' Jeff Hrkach, there are big things in store for the tiny drug carriers.

Alnylam joins Spanish team to deliver successful RNAi

Researchers at Barcelona's Vall d'Hebron Institute of Oncology in Spain and U.S. biotech Alnylam Pharmaceuticals have shown that, with a novel delivery technique, they can actively "silence" cancer genes with molecules using the selective interference technique, RNAi.

Cloaked nanoparticles look like blood cells, carry drugs

Call it the Trojan horse of nanomedicine: Researchers have developed a way to cloak drug-carrying nanoparticles with the same membranes as the body's own white blood cells, allowing those drugs to bypass the immune system without being harmed.

Silk-protein combo spins better delivery

Researchers at the Indian Institute of Technology Kharagpur have created nanoparticles out of silk fibers that can deliver drugs to specific targets when combined with other proteins.

Heated magnet nanoparticles target cells, release drugs

Researchers in Switzerland have created a novel drug delivery system using nanosized magnets to deliver toxic drugs to specific parts of a patient's body. The triggered delivery is a step toward creating "intelligent" drugs with highly targeted functions.

Texas researchers aim to spur lung growth with nanoparticles

Researchers at the University of Texas at Arlington and UT Southwestern Medical Center are developing a drug delivery system that uses nanoparticles to bring regenerative drugs into the lungs.

Abraxane boosts pancreatic cancer survival, but not as much as hoped

The combination of Celgene's Abraxane with gemcitabine has improved survival in advanced pancreatic cancer by almost two months, but this isn't as much as some doctors were hoping for, according to a report in  The New York Times .

Particles with a heart of gold attack lymphoma without drugs

If Northwestern Medicine's mouse studies come good, then in the future, doctors could treat lymphoma without toxic drugs with something as simple as minute particles of gold. These block the entry of HDL cholesterol and starve the cancer cells to death, according to new research in PNAS .

Quiet Therapeutics readies to make noise in nanoparticle delivery

Israeli company Quiet Therapeutics has captured funding of $5.5 million to develop its nanoparticle-based delivery system for RNAi and small-molecule drugs for cancer and inflammation.